Monoclonal antibodies (mAbs) can be used therapeutically by binding to molecular targets
with high specificity. Therefore, they have excellent therapeutic applications in …

Biologic therapies have increased the treatment options for sight-threatening uveitis. Despite
experimental rationale, the lack of evidence from randomized controlled studies limits our …

Rheumatoid arthritis (RA) is a systemic inflammatory disease associated with a number of
extra-articular organ manifestations. Ocular manifestations involved with RA are …

Background/aims To evaluate retrospectively the long-term efficacy of rituximab in patients
with severe juvenile idiopathic arthritis (JIA)-associated uveitis. Methods Eight patients (15 …

Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of
sight loss in the working population. Most uveitis seen in Western countries is noninfectious …

Objective To investigate the long-term efficacy and safety of low-dose and dose-escalating
therapy of interferon alfa-2a in the treatment of Behçet uveitis. Methods This study included …

Introduction: Uveitis is a challenging disease covering both infectious and noninfectious
conditions. The current treatment strategies are hampered by the paucity of randomized …

Sympathetic ophthalmia is a rare bilateral diffuse granulomatous panuveitis that usually
results from surgical or penetrating trauma to one eye. The symptoms range from impaired …

Scleral inflammatory disorders, with their extensive differential diagnoses and sometimes as
controversial treatment options, pose both diagnostic and clinical challenges for physicians …

Ocular myositis represents a subgroup within the idiopathic orbital inflammatory syndrome,
formerly termed orbital pseudotumor. Ocular myositis describes a rare inflammatory disorder …